semaglutide bmi Mind-blowing' weight loss with extends to adolescents with obesity FDA approves obesity drug that

patients with gallbladder disease history require careful consideration Thyroid C-cell tumors : Tirzepatide carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies, though human relevance remains uncertain

Therefore, patients should inform their healthcare provider of any medications they are currently taking before starting this formulation

The end-result

The new guidelines bolster a major international shift from treating obesity as a lifestyle condition, which has tacitly enabled stigmatisation and blame, to recognising obesity as a chronic, relapsing disease that requires lifelong care

While studies are limited with mixed results, the benefits are promising

It can also backfire spectacularly